SPHEROTEC Trademark

Trademark Overview


On Tuesday, October 21, 2008, a trademark application was filed for SPHEROTEC with the United States Patent and Trademark Office. The USPTO has given the SPHEROTEC trademark a serial number of 79067099. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, October 21, 2018. This trademark is owned by SpheroTec GmbH. The SPHEROTEC trademark is filed in the Chemical Products, Pharmaceutical Products, Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Scaffold-free and solid phase free chemical and chemical preparations used in tissue and cell-based spheroid cultures for scientific purposes; chemical preparations, namely, collections of biological tissues and cells for scientific purposes; tissue in the nature of biological tissue, namely, blood, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; fixed arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; biological cells prepared into a format for scientific purposes and research for scientific research use; cell cult...

Scaffold-free or solid phase free pharmaceutical and veterinary preparations used in tissue and cell-based spheroid cultures for the diagnosis and treatment of cancer; collection of biological tissue and cells, namely, surgical tissues and cells intended for the generation of cell clusters and cell aggregates for medical purposes; tissue, namely, surgical tissues, for diagnosis and treatment of cancer and for medical purposes; fibroblasts, foam cells, glial cells, stem cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells for the generation of cell clusters or cell aggregates

Compilation and management of computerized databases used for tissue and cell-based spheroid cultures

Scientific and technological services and research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; computer diagnostic services; diagnostic testing of humans for medical research purposes; medical research services; medical research in the field of oncology; medical research in the field of disease indications and identification of tumor indications; testing of drugs, biological and chemical preparations for medical research purposes; pharmaceutical research, inspection and development; pharmaceutical drug development services; medical and scientific research, namely, conducting clinical trials concerning biological and chemical preparations and pharmaceuticals; medical and scientific research, namely, researching profiles of biological and chemical preparations, pharmaceuticals, antigens; testing for scientific and medical research purposes of combinations of biological and ch...

Medical and veterinary services; medical diagnostic testing services; medical diagnostic testing services of humans; medical diagnostic and clinical testing services; medical and clinical oncology diagnostic testing services for humans; medical diagnostic testing services in the field of oncology; performing diagnosis of disease indications, performing diagnosis of tumour disease indications; medical screening services for drugs, biological and chemical entities and potential and known pharmaceuticals; medical services, namely, medical testing for and identifying antigens and providing drug therapy for inhibiting antigens; providing individualizing cancer therapy services; providing medical diagnostic services for cancer therapy; medical services, namely, personalized cancer therapy; medical services, namely, radiotherapy; medical services, namely, radiochemotherapy; medical services, namely, preparations of ex-vivo therapies; all relating to medical and veterinary fields; all of the a...
spherotec

General Information


Serial Number79067099
Word MarkSPHEROTEC
Filing DateTuesday, October 21, 2008
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, October 21, 2018
Registration Number4434280
Registration DateTuesday, November 19, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 7, 2012

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesScaffold-free and solid phase free chemical and chemical preparations used in tissue and cell-based spheroid cultures for scientific purposes; chemical preparations, namely, collections of biological tissues and cells for scientific purposes; tissue in the nature of biological tissue, namely, blood, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; fixed arrays of biological cells, namely, cancer cells, benign cells, stem cells, tumour cells, fibroblasts, foam cells, glial cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells; biological cells prepared into a format for scientific purposes and research for scientific research use; cell culture systems, three-dimensional cell culture system comprising cell clusters and aggregates for scientific research use
Goods and ServicesScaffold-free or solid phase free pharmaceutical and veterinary preparations used in tissue and cell-based spheroid cultures for the diagnosis and treatment of cancer; collection of biological tissue and cells, namely, surgical tissues and cells intended for the generation of cell clusters and cell aggregates for medical purposes; tissue, namely, surgical tissues, for diagnosis and treatment of cancer and for medical purposes; fibroblasts, foam cells, glial cells, stem cells, adipocytes, benign and malignant primary cells, hybridomas, antibody producing cells for the generation of cell clusters or cell aggregates
Goods and ServicesCompilation and management of computerized databases used for tissue and cell-based spheroid cultures
Goods and ServicesScientific and technological services and research and design in the field of integrated system architecture that allows for the rapid development of highly interactive and customizable learning applications; computer diagnostic services; diagnostic testing of humans for medical research purposes; medical research services; medical research in the field of oncology; medical research in the field of disease indications and identification of tumor indications; testing of drugs, biological and chemical preparations for medical research purposes; pharmaceutical research, inspection and development; pharmaceutical drug development services; medical and scientific research, namely, conducting clinical trials concerning biological and chemical preparations and pharmaceuticals; medical and scientific research, namely, researching profiles of biological and chemical preparations, pharmaceuticals, antigens; testing for scientific and medical research purposes of combinations of biological and chemical preparations and pharmaceuticals; testing for medical research purposes to determine the chemo-resistance and chemo-sensitivity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the efficacy and toxicity of biological and chemical preparations and pharmaceuticals; medical research in the nature of testing the effects of biological and chemical preparations and pharmaceuticals on cell toxicity levels; medical research in the nature of pharmacokinetic testing of biological and chemical substances and known pharmaceuticals; medical research concerning the absorption, delivery, metabolism, excretion and toxicity testing of biological and chemical preparations and pharmaceuticals ; medical and scientific research in the field of pharmaceuticals, genetic changes induced by biological or chemical preparations or pharmaceuticals, and pharmaceutical dosing levels; research and development of pharmaceutical treatment therapies for others; scientific research concerning tumour biology, progression and metastasis; medical research concerning optimal treatment and therapy regimes for individuals; medical research concerning optimal cancer therapy for individuals; research and development of new products for others in relation to prediction of cancer therapy; scientific and medical research in the field of radiotherapy; research, development and design of new radiotherapy products for others; scientific and medical research in the field of radiochemotherapy; research, development and design of new products for others in the field of radiochemotherapy; scientific and medical research in the field of stem cells and biomarker discovery, characterization and development; medical research in the fields of ex-vivo therapies, patient material profiling, tumor profiling, in vitro modeling of tissue and biological systems, cell culture systems, three-dimensional cell culture systems, and three-dimensional culture of donor and patient cells; laboratory research services, namely, isolation, culture and treatment of donor and patient tissues and cells for medical research purposes; research laboratory services, namely, preparation of cell lines, primary tissues and fluids, and biological material into a format for scientific and medical research purposes; medical research concerning immunohistology, immunohistology preparation and investigation;Opposition No. 912064346research laboratory services, namely, creation and preparation of biological material into or onto a format for immunohistology investigation, creation and preparation of biological material on a solid or wax support, preparation of sections or slices of biological material on to slides, all for medical research purposes; medical research concerning small molecule development, preparation and generation, antibody research, development, preparation and generation, and vaccine research, development, preparation and generation; provision of information and data relating to scientific and technological research and development; provision of information and data relating to medical and veterinary research and development; provision of information and data relating to scientific and medical research concerning pharmaceuticals, drug testing, drug discovery and development, and testing of biological material; all of the aforementioned services relating to or using tissue and cell-based spheroids cultures
Goods and ServicesMedical and veterinary services; medical diagnostic testing services; medical diagnostic testing services of humans; medical diagnostic and clinical testing services; medical and clinical oncology diagnostic testing services for humans; medical diagnostic testing services in the field of oncology; performing diagnosis of disease indications, performing diagnosis of tumour disease indications; medical screening services for drugs, biological and chemical entities and potential and known pharmaceuticals; medical services, namely, medical testing for and identifying antigens and providing drug therapy for inhibiting antigens; providing individualizing cancer therapy services; providing medical diagnostic services for cancer therapy; medical services, namely, personalized cancer therapy; medical services, namely, radiotherapy; medical services, namely, radiochemotherapy; medical services, namely, preparations of ex-vivo therapies; all relating to medical and veterinary fields; all of the aforementioned services relating to or using tissue and cell-based spheroids cultures
Pseudo MarkSPHERO TECH

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, October 21, 2018
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, October 21, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, October 21, 2018
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, October 21, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status CodeH - NOT AVAILABLE
Class Status DateSunday, October 21, 2018
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSpheroTec GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party NameSpheroTec GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameSpheroTec GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Friday, May 24, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, May 24, 2019DEATH OF INTERNATIONAL REGISTRATION
Monday, November 19, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, March 6, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, February 19, 2014FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 19, 2014FINAL DISPOSITION PROCESSED
Wednesday, February 19, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, November 19, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, October 16, 2013TTAB RELEASE CASE TO TRADEMARKS
Wednesday, October 16, 2013OPPOSITION TERMINATED NO. 999999
Wednesday, October 16, 2013OPPOSITION DISMISSED NO. 999999
Monday, September 23, 2013PAPER RECEIVED
Friday, February 8, 2013ASSIGNED TO EXAMINER
Saturday, September 8, 2012REFUSAL PROCESSED BY IB
Tuesday, August 7, 2012OPPOSITION INSTITUTED NO. 999999
Monday, August 6, 2012OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Saturday, August 4, 2012OPPOSITION NOTICE (IB REFUSAL) CREATED
Thursday, February 23, 2012EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 7, 2012PUBLISHED FOR OPPOSITION
Friday, February 3, 2012NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, January 26, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 18, 2012NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, January 18, 2012NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 18, 2012NOTICE OF PUBLICATION
Tuesday, January 3, 2012EXAMINERS AMENDMENT MAILED
Saturday, December 31, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 30, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 30, 2011EXAMINER'S AMENDMENT ENTERED
Friday, December 30, 2011EXAMINERS AMENDMENT -WRITTEN
Friday, December 30, 2011PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, November 22, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 18, 2011LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, April 18, 2011REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, October 18, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Saturday, October 9, 2010NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, September 23, 2010NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, September 23, 2010NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, April 16, 2010REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, April 16, 2010ASSIGNED TO LIE
Friday, October 16, 2009LETTER OF SUSPENSION MAILED
Thursday, October 15, 2009SUSPENSION LETTER WRITTEN
Monday, September 28, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 28, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 28, 2009ASSIGNED TO LIE
Thursday, September 24, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 23, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 23, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, June 5, 2009REFUSAL PROCESSED BY IB
Monday, May 11, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 11, 2009REFUSAL PROCESSED BY MPU
Saturday, May 9, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 8, 2009NON-FINAL ACTION WRITTEN
Tuesday, April 28, 2009APPLICATION FILING RECEIPT MAILED
Friday, April 24, 2009ASSIGNED TO EXAMINER
Friday, April 24, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 23, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB